Critics continue pounding 21st Century Cures Act for threatening patient safety

Opponents of the 21st Century Cures Act, which is intended to accelerate the transfer of scientific advances in genetics into treatment for patients, say the legislation will threaten patient safety by easing FDA rules intended to protect patients from unproven therapies, according to Medical Economics. 

Critics argue looser FDA rules will result in drug approvals without the level of rigorous testing currently required. 

The legislation "would lead to less effective drugs being put on the marketplace," James Rickert, M.D., president of the Society for Patient Centered Orthopedic Surgery in Bloomington, Indiana, told the publication. "People are always looking for new and better treatments but new and better treatments that are not properly vetted come with considerable risk," he says.

FierceHealthIT has reported similar concerns from doctors who say that new drugs and medical devices will be less safe and effective and cost more, and that the bill sacrifices long-term value to public health.

The bill was passed by the House of Representatives in July and the Senate is supposed to take on the legislation in early 2016.

To learn more:
- read the article



Suggested Articles

From medical malpractice risks to privacy protocols, there are a number of factors that physicians need to consider when reopening, the AMA says.

The strain of COVID-19 on practices may be easing, but the overall picture for primary care remains tenuous, according to a new survey.

Telehealth is here to stay, long after the current COVID-19 crisis abates. Here is what the rise in virtual care means for providers and for patients.